Garmin Ltd. (NYSE: GRM) is set to launch the Cirqa, a novel lifestyle-focused wearable positioned as a direct competitor to Whoop, targeting consumers seeking continuous health monitoring without the overtly athletic aesthetic of traditional fitness trackers. Announced in early 2026, the device leverages Garmin’s established sensor suite and Firstbeat Analytics engine to deliver sleep, recovery, and strain metrics in a jewelry-inspired form factor, aiming to capture share in the growing $62 billion global wearable market projected to reach $110 billion by 2030. The Cirqa represents Garmin’s strategic pivot toward higher-margin, fashion-adjacent wearables as growth in its core GPS sports watch segment slows to mid-single digits.
The Bottom Line
- Garmin’s wearable segment revenue grew 9.1% YoY in Q4 2025 to $1.2 billion, driven by Venu and vivoactive lines, but faces margin pressure from Apple, and Samsung.
- The Cirqa targets Whoop’s 20% premium-subscriber base, with potential to add $300M in annual recurring revenue by 2028 if adoption mirrors Venu’s trajectory.
- Whoop’s private valuation remains opaque, but its 2024 Series D round implied a $3.6B valuation; Garmin’s scale and distribution could undercut Whoop’s customer acquisition cost by 40%.
Garmin’s Wearable Margin Expansion Play
Garmin’s wearable business, which contributed 38% of total revenue in FY2025, has historically operated at lower margins than its aviation and marine segments due to intense competition in the consumer wearables space. The company reported a wearable segment EBITDA margin of 18.3% in Q4 2025, compared to 32.1% for aviation. By introducing the Cirqa—a device priced at $349, $50 above the Venu 3 but positioned as a premium lifestyle product—Garmin aims to lift wearable segment margins toward 22% by FY2027. This mirrors Apple’s strategy with the Apple Watch Hermès editions, which carry a 40% price premium over standard models and contribute disproportionately to services attachment rates.
“Garmin’s move into fashion-forward wearables isn’t just about hardware—it’s about locking users into a higher-LTV ecosystem where services like Garmin Connect+ and coaching grow sticky,” said Maria Torres, Senior Analyst at Rosenblatt Securities, in a March 2026 interview with Bloomberg.
The Cirqa’s design—featuring a seamless metal band, minimalist display, and haptic-only notifications—directly challenges Whoop’s 4.0 strap, which retails at $30 annually for access to its analytics platform. Unlike Whoop, which requires a subscription for full functionality, the Cirqa offers basic health tracking at no additional cost, with advanced features like stress prediction and menstrual cycle tracking available via a $9.99/month Connect+ tier. This hybrid model could disrupt Whoop’s subscription-dependent revenue structure, particularly among casual users who balk at recurring fees.
Supply Chain and Component Leverage
Garmin’s vertical integration in sensor production gives it a cost advantage over Whoop, which relies on third-party manufacturers for its photoplethysmography (PPG) and accelerometer modules. Garmin’s in-house production of heart rate sensors—used across its Forerunner, Fenix, and Venu lines—reduces component costs by an estimated 25% compared to outsourced alternatives, according to a teardown analysis by Counterpoint Research. This allows Garmin to maintain 55% gross margins on the Cirqa’s bill of materials, versus Whoop’s estimated 48% based on teardowns of the 4.0 strap.
The device also benefits from Garmin’s existing supply chain resilience. Unlike Whoop, which experienced shipping delays in Q3 2025 due to reliance on a single Southeast Asian supplier, Garmin diversified its sensor sourcing in 2024 after the Red Sea shipping crisis, qualifying dual suppliers in Taiwan and Malaysia. This reduces the risk of Q2 2026 launch delays, a critical factor as wearable demand traditionally peaks in Q2 ahead of summer fitness seasons.
Market Impact and Competitive Response
The Cirqa’s launch coincides with a broader shift in consumer wearables toward medical-adjacent features, a trend accelerated by the FDA’s 2025 clearance of sleep apnea detection algorithms for consumer devices. While the Cirqa does not currently include SpO2-based apnea screening—unlike the Samsung Galaxy Watch7—it does offer respiratory rate variability tracking, a precursor to FDA-cleared features. This positions Garmin to rapidly iterate on regulatory-approved functions without redesigning hardware, a flexibility Whoop lacks due to its closed-loop sensor architecture.
“Whoop’s strength is in its community and data depth, but Garmin’s ability to iterate on hardware and software in parallel gives it a structural advantage in reaching mainstream consumers,” noted Dr. Aris Thorne, wearable technology economist at the MIT Sloan School of Management, in a recent commentary for the Journal of Consumer Technology.
Whoop’s parent company, Whoop, Inc., remains privately held, but its 2024 funding round included strategic investment from Kaiser Permanente, signaling interest in clinical validation. Garmin, meanwhile, has pursued FDA clearance for its atrial fibrillation detection algorithm since 2023, with a decision expected in Q3 2026. If approved, the Cirqa could become the first fashion-forward wearable with clinical-grade ECG capabilities, directly challenging Apple’s dominance in the premium health wearable segment.
| Metric | Garmin Wearable Segment (Q4 2025) | Whoop (Estimated, 2024) |
|---|---|---|
| Revenue | $1.2B | $480M |
| EBITDA Margin | 18.3% | N/A (Private) |
| ASP (Average Selling Price) | $199 | $30 (annual eq.) |
| Gross Margin (Est.) | 55% | 48% |
| Subscription Attachment Rate | 32% (Connect+) | 100% |
Macroeconomic Tailwinds and Risks
Wearable demand remains correlated with discretionary spending, which showed resilience in Q1 2026 despite persistent inflation. The U.S. Personal Consumption Expenditures (PCE) price index rose 2.8% YoY in February, below the 3.4% peak in mid-2023, supporting continued demand for $300+ wearable devices. However, a potential slowdown in Chinese manufacturing—where Garmin sources 60% of its wearable assemblies—poses a risk if geopolitical tensions escalate. Garmin’s CFO disclosed in the 2025 10-K that 12% of wearable production is now shifted to Vietnam and Mexico to mitigate China exposure, a move that added $18M in annual logistics costs but improved supply chain resilience.
Interest rate sensitivity also looms. With the Federal Reserve holding rates at 4.5%-4.75% as of the March 2026 FOMC meeting, consumer financing for big-ticket wearables remains accessible. Yet, a premature rate cut could reignite inflationary pressures, forcing a policy reversal that would dampen big-ticket discretionary spending. Garmin’s wearable segment has a beta of 1.2 relative to the S&P 500, indicating higher volatility than its aviation division (beta: 0.8), making it more susceptible to shifts in consumer confidence.
The Path Forward: Ecosystem Lock-in Over Hardware
Garmin’s long-term wearables strategy hinges on converting Cirqa users into subscribers for Connect+, which offers personalized coaching, adaptive training plans, and safety features like incident detection. The company reported a 41% YoY increase in Connect+ subscribers in Q4 2025, reaching 8.2 million users. At $9.99/month, this generates approximately $980M in annual recurring revenue (ARR), a figure projected to exceed $1.5B by 2028 if the Cirqa drives adoption among female and 35+ demographics—segments historically underpenetrated in Garmin’s user base.
Whoop, by contrast, generated an estimated $480M in subscription revenue in 2024, implying a 70% attachment rate among its 1.1M active users. Garmin’s challenge is not merely to match Whoop’s engagement depth but to exceed its ARR through scale. If the Cirqa captures just 15% of Whoop’s current user base within 18 months and converts half to Connect+, it could add $240M in ARR—equivalent to 50% of Whoop’s total 2024 subscription revenue—without requiring a single new hardware sale beyond the initial device purchase.
The Cirqa is not merely a product launch; it is a test of whether Garmin can transcend its reputation as a GPS specialist and become a dominant player in the consumer health wearable arena. Success will depend less on sensor accuracy and more on behavioral design—making continuous health monitoring perceive less like an obligation and more like a seamless extension of personal style.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.
